To explore the clinical characteristics of and analyze the risk factors for hydrocephalus in children with bacterial meningitis.
Methods:
Retrospective study of a sample of children with bacterial meningitis seen on the pediatric service of Shengjing Hospital of China Medical University between January 1, 2010, and December 31, 2016.
Results:
Overall, 9.36% (25/267) of patients presented with hydrocephalus. Among patients with hydrocephalus, the age at onset of bacterial meningitis was usually <6 months, 15 patients had confirmed bacterial etiology, and 1 patient died. The most significant results of multivariate analysis for hydrocephalus were a rural living situation, altered level of consciousness, previous treatment with antibiotics, initial cerebrospinal fluid protein >2 g/L, C-reactive protein >100 mg/L, and dexamethasone use.
Conclusions:
A severe clinical manifestation and significant laboratory index at admission are the most important predictors of hydrocephalus in children with bacterial meningitis.
BlackRECousensSJohnsonHL. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet. 2010;375:1969–1987.
2.
GuoLing-yunZhangZhi-xiaoXiWanga. Clinical and pathogenic analysis of 507 children with bacterial meningitis in Beijing, 2010–2014. Int J Infect Dis. 2016;50:38–43.
3.
TheodoridouMNVasilopoulouVAAtsaliEE. Meningitis registry of hospitalized cases in children: epidemiological patterns of acute bacterial meningitis throughout a 32-year period. BMC Infect Dis. 2007;7:101.
4.
EdmondKClarkAKorczakVS. Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10(5):317–328.
5.
Soemirien KasanmoentalibEBrouwerMCvan der EndeA. Hydrocephalus in adults with community-acquired bacterial meningitis. Neurology. 2010;75:918–923.
6.
GaschignardJLevyCRomainO. Neonatal bacterial meningitis: 444 cases in 7 years. Pediatr Infect Dis J. 2011;30(3):212–217.
7.
MartinezEMintegiSVilarB. Prevalence and predictors of bacterial meningitis in young infants with fever without a source. Pediatr Infect Dis J. 2015;34(5):494–498.
8.
van de BeekDCabellosCDzupovaO. ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect. 2016;22(3):S37–S62.
9.
TomaAKHollEKitchenND. Evans’ index revisited: the need for an alternative in normal pressure hydrocephalus. Neurosurgery. 2011;68:939–944.
10.
AntoniukSAHamdarFDucciRD. Childhood acute bacterial meningitis: risk factors for acute neurological complications and neurological sequelae. J Pediatr (Rio J). 2011;87:535–540.
11.
NamaniSMilenkovicZKucharEKociRMehmetiM. Mortality from bacterial meningitis in children in Kosovo. J Child Neurol. 2012;27(1):46–50.
12.
AndersonVAndersonPGrimwoodKNolanT. Cognitive and executive function 12 years after childhood bacterial meningitis: effect of acute neurologic complications and age of onset. J Pediatr Psychol. 2004;29(2):67–81.
13.
Chávez-BuenoSMcCrackenGHJr. Bacterial meningitis in children. Pediatr Clin North Am. 2005;52:795–810.
14.
van de BeekDde GansJTunkelAR. Community-acquired bacterial meningitis in adults. N Engl J Med. 2006;354(1):44–53.
15.
ArditiMMasonEOJrBradleyJS. Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use. Pediatrics. 1998;102(5):1087–1097.
16.
BodilsenJSchonheyderHCNielsenH. Hydrocephalus is a rare outcome in community-acquired bacterial meningitis in adults: a retrospective analysis. BMC Infect Dis. 2013;13:321.
17.
de JongeRCvan FurthAMWassenaarM. Predicting sequelae and death after bacterial meningitis in childhood: a systematic review of prognostic studies. BMC Infect Dis. 2010;10:232.
18.
LoveraDArboA. Risk factors for mortality in Paraguayan children with pneumococcal bacterial meningitis. Trop Med Int Health. 2005;10:1235–1241.
19.
SrinivasanLRamananR. Hydrocephalus secondary to group B streptococcal meningitis. J Matern Fetal Neonatal Med. 2004;16(1):67–68.
20.
NamaniSAKociBMMilenkovićZ. Early neurologic complications and long-term sequelae of childhood bacterial meningitis in a limited-resource country (Kosovo). Childs Nerv Syst. 2013;29(2):275–280.
21.
VasilopoulouVAKaranikaMTheodoridouK. Prognostic factors related to sequelae in childhood bacterial meningitis: data from a Greek meningitis registry. BMC Infect Dis. 2011;11:214.
22.
PaglianoPFuscoUAttanasioV. Pneumococcal meningitis in childhood: a longitudinal prospective study. FEMS Immunol Med Microbiol. 2007;51:488–495.
23.
RoineIPeltolaHFernándezJ. Influence of admission findings on death and neurological outcome from childhood bacterial meningitis. Clin Infect Dis. 2008;46:1248–1252.
24.
PelkonenTRoineIMonteiroL. Risk factors for death and severe neurological sequelae in childhood bacterial meningitis in sub-Saharan Africa. Clin Infect Dis. 2009;48:1107–1110.
25.
ChaoYNChiuNCHuangFY. Clinical features and prognostic factors in childhood pneumococcal meningitis. J Microbiol Immunol Infect. 2008;41:48–53.
26.
VergouwenMDSchutESTroostD. Cerebral intravascular coagulation and cerebral infarction in pneumococcal meningitis. Neurocrit Care. 2010;13(2):217–227.
27.
MolyneuxEMWalshALForsythH. Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial. Lancet. 2002;360:211–218.
28.
SadieNamaniZvonkoMilenkovićBulíaKoci. A prospective study of risk factors for neurological complications in childhood bacterial meningitis. J Pediatr (Rio J). 2013;89(3):256–262.
